Motilin vs Teduglutide
Head-to-head comparison of Motilin (Motilin) and Teduglutide (Teduglutide (glycyl-2 human glucagon-like peptide-2 analog)) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Motilin | Teduglutide |
|---|---|---|
| Category | Gastrointestinal | Gastrointestinal |
| Full Name | Motilin | Teduglutide (glycyl-2 human glucagon-like peptide-2 analog) |
| Molecular Weight | ~2.7 kDa | 3752 Da |
| Half-Life | ~20 min | approximately 2-3 hours |
| Amino Acids | 22 | 33 |
| Typical Dose | No standard approved dose; experimental use only | 0.05 mg/kg/day |
| Route | IV|SC | Subcutaneous |
| Purity | ≥98% | ≥98% |
| Studies Count | 81 | 300 |
| Research Status | Endogenous | Clinical |
Motilin Benefits
- ✓migrating motor complex support
- ✓gastric emptying
- ✓small-bowel clearance
Teduglutide Benefits
- ✓mucosal-growth
- ✓absorption-support
- ✓barrier-repair
- ✓intestinal-adaptation
Motilin Dosing
0.1–1 mg (experimental)|IV/SC
Teduglutide Dosing
0.05 mg/kg once daily subcutaneous injection|chronic maintenance dosing in approved use|monitor fluid status and intestinal anatomy
Motilin Side Effects
- ⚠cramping
- ⚠nausea
Teduglutide Side Effects
- ⚠abdominal pain
- ⚠fluid retention
- ⚠polyp/neoplasia monitoring needed
Research Overview
Motilin
Motilin is a 22-amino-acid peptide released from the upper small intestine and is one of the classic physiologic prokinetic signals. It is a real peptide target for GI motility research, though not commonly used as a standard drug.
Teduglutide
Teduglutide has robust clinical evidence showing improved intestinal absorption and reduced parenteral nutrition dependence in short bowel syndrome. Its mechanism, via GLP-2 receptor activation, makes it highly relevant to mucosal healing and intestinal adaptation research.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.